跳至主要内容
临床试验/ACTRN12610000397011
ACTRN12610000397011招募中2 期

The effect of low dose colchicine(1mg/dy) administered to patients with stable coronary artery disease compared with no treatment on brachial artery flow mediated dilation and blood inflammatory markers.

Pfizer Cardiovascular Lipid Research Grant0 个研究点目标入组 40 人开始时间: 2010年5月18日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 18 to 80 years old.
  • Male and female.
  • History of proven coronary artery disease by coronary agnigraphy. (>50% stenosis of epicardial coronary artery or requirement for percutaneous coronary intervention)
  • Stable for >1 month
  • No significant co-morbidity that will affect followup.
  • No contraindication to colchicine use.

排除标准

  • Any patient who is not deemed to have stable coronary artery disease.
  • Mild coronary artery disease.
  • Advanced heart failure (New York Heart Association grade 3 or 4).
  • Renal failure with creatnine clearance(<30ml/min/1.73m2).
  • Known malignancy.
  • Inflammatory bowel disease.
  • Requirement for cyclosporine or other drugs that may interact with colchicine.
  • Known sensitivity to colchicine.
  • Pregnancy or contemplated pregnancy during the study period.

研究者

发起方
Pfizer Cardiovascular Lipid Research Grant

相似试验

oDoCo - VRIC Low Dose Colchicine in stable coronary... | 临床试验